125 related articles for article (PubMed ID: 19086969)
1. Columnar-lined esophagus without intestinal metaplasia should not be dismissed as having no cancer risk.
Kelty C
Am J Gastroenterol; 2008 Dec; 103(12):3205; author reply 3205-6. PubMed ID: 19086969
[No Abstract] [Full Text] [Related]
2. Barrett's oesophagus: intestinal metaplasia is not essential for cancer risk.
Kelty CJ; Gough MD; Van Wyk Q; Stephenson TJ; Ackroyd R
Scand J Gastroenterol; 2007 Nov; 42(11):1271-4. PubMed ID: 17852872
[TBL] [Abstract][Full Text] [Related]
3. Relevance of the detection of intestinal metaplasia in non-dysplastic columnar-lined oesophagus.
Gatenby PA; Ramus JR; Caygill CP; Shepherd NA; Watson A
Scand J Gastroenterol; 2008; 43(5):524-30. PubMed ID: 18415743
[TBL] [Abstract][Full Text] [Related]
4. Adiposity and columnar-lined esophagus.
Lenglinger J; Eisler M; Riegler FM
Am J Gastroenterol; 2008 May; 103(5):1316-7. PubMed ID: 18477363
[No Abstract] [Full Text] [Related]
5. Predicting presence of intestinal metaplasia and dysplasia in columnar-lined esophagus: a multivariate analysis.
Kerkhof M; Steyerberg EW; Kusters JG; Kuipers EJ; Siersema PD
Endoscopy; 2007 Sep; 39(9):772-8. PubMed ID: 17703384
[TBL] [Abstract][Full Text] [Related]
6. Histology of metaplasia and dysplasia in Barrett's esophagus.
Yerian L
Surg Oncol Clin N Am; 2009 Jul; 18(3):411-22. PubMed ID: 19500733
[TBL] [Abstract][Full Text] [Related]
7. Keratin 7 expression as an early marker of reflux-related columnar mucosa without intestinal metaplasia in the esophagus.
Cabibi D; Fiorentino E; Pantuso G; Mastrosimone A; Callari C; Cacciatore M; Campione M; Aragona F
Med Sci Monit; 2009 May; 15(5):CR203-210. PubMed ID: 19396034
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group.
Menke-Pluymers MB; Hop WC; Dees J; van Blankenstein M; Tilanus HW
Cancer; 1993 Aug; 72(4):1155-8. PubMed ID: 8339208
[TBL] [Abstract][Full Text] [Related]
9. Cardiac rather than intestinal-type background in endoscopic resection specimens of minute Barrett adenocarcinoma.
Takubo K; Aida J; Naomoto Y; Sawabe M; Arai T; Shiraishi H; Matsuura M; Ell C; May A; Pech O; Stolte M; Vieth M
Hum Pathol; 2009 Jan; 40(1):65-74. PubMed ID: 18755496
[TBL] [Abstract][Full Text] [Related]
10. [Relevance of intestinal metaplasia at the gastroesophageal junction].
Valenzuela J
Rev Med Chil; 1998 Oct; 126(10):1268-70. PubMed ID: 10030101
[No Abstract] [Full Text] [Related]
11. Evidence for chief cells within columnar-lined esophagus?
Lenglinger J; Eisler M; Riegler M
Surgery; 2006 Sep; 140(3):479. PubMed ID: 16934615
[No Abstract] [Full Text] [Related]
12. The location of intestinal metaplasia within a columnar-lined esophagus.
DeMeester SR
Am J Gastroenterol; 2008 Jan; 103(1):250-1. PubMed ID: 18184138
[No Abstract] [Full Text] [Related]
13. Editorial: Defining a bad Barrett's segment: is it dependent on goblet cells?
Vieth M; Barr H
Am J Gastroenterol; 2009 Apr; 104(4):825-7. PubMed ID: 19343024
[TBL] [Abstract][Full Text] [Related]
14. When and how to grade Barrett's columnar metaplasia: the Prague system.
Anand O; Wani S; Sharma P
Best Pract Res Clin Gastroenterol; 2008; 22(4):661-9. PubMed ID: 18656823
[TBL] [Abstract][Full Text] [Related]
15. Paris Workshop on Columnar Metaplasia in the Esophagus and the Esophagogastric Junction, Paris, France, December 11-12 2004.
Endoscopy; 2005 Sep; 37(9):879-920. PubMed ID: 16116544
[No Abstract] [Full Text] [Related]
16. Cancer incidence in Barrett's esophagus: does it really matter, and who's counting anyway?
Corley DA
Gastrointest Endosc; 2008 Mar; 67(3):399-401. PubMed ID: 18294502
[No Abstract] [Full Text] [Related]
17. Diagnosis and recognition of early esophageal neoplasia.
Herszényi L; Pregun I; Tulassay Z
Dig Dis; 2009; 27(1):24-30. PubMed ID: 19439957
[TBL] [Abstract][Full Text] [Related]
18. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of adenocarcinoma associated with Barrett's esophagus: potential options.
Neumann H; Mönkemüller K; Vieth M; Malfertheiner P
Dig Dis; 2009; 27(1):18-23. PubMed ID: 19439956
[TBL] [Abstract][Full Text] [Related]
20. [Regression of cylindrical epithelial metaplasia in Barrett esophagus].
Ottenjann R; Heidt H
Dtsch Med Wochenschr; 1990 Jun; 115(23):916-7. PubMed ID: 2354665
[No Abstract] [Full Text] [Related]
[Next] [New Search]
